Results 91 to 100 of about 279,308 (307)
Patient‐specific induced pluripotent stem cells (iPSCs) can be differentiated into alveolar type II cells (iAT2s), expanded as 3D alveolospheres, and grown at physiologically relevant air–liquid interface (ALI). This study shows for the first time the infectability of iAT2s by the influenza A virus (IAV) and proves their responsiveness to the well ...
Lena Gauthier +7 more
wiley +1 more source
Online education improves competence in identifying fibrodysplasia ossificans progressiva (FOP)
Christy Rohani-Montez +2 more
doaj +1 more source
New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province
Objectives To seek a triple combination of biomarkers for early diagnosis of chronic kidney disease-mineral and bone metabolic disorder and to explore the diagnostic efficacy of β2-microglobulin, parathyroid hormone and blood urea nitrogen in chronic ...
Yun Zhou +9 more
doaj +1 more source
Frequency of metabolic syndrome in Paget's disease of bone
Rumeysa Selvinaz Erol
openalex +1 more source
Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases [PDF]
Tanuj Puri +5 more
openalex +1 more source
Cell Calcification Models and Their Implications for Medicine and Biomaterial Research
Calcification, is the process by which the tissues containing minerals are formed, occurring during normal physiological processes, or in pathological conditions. Here, it is aimed to give a comprehensive overview of the range of cell models available, and the approaches taken by these models, highlighting when and how methodological divergences arise,
Luke Hunter +5 more
wiley +1 more source
1155 Screening and Treatment Strategies for Metabolic Bone Disease in Preterm Infants: Results of a National Questionnaire Survey in the Netherlands [PDF]
Fenna Visser, Arwen Sprij, Frank Brus
openalex +1 more source
The repair and regeneration of brain tissue faces both biological and technical challenges. Injectable bioscaffolds offer new opportunities to stimulate tissue regrowth in the brain by recruiting neural stem cells. Here, the translational issues are reviewed that need to be address to advance this promising new therapeutic approach from the bench to ...
Michel Modo, Alena Kisel
wiley +1 more source
Bone metabolic diseases are typically caused by abnormal cell metabolism and cell death within the bone, involving cell types such as osteoblasts, osteoclasts, osteocytes, chondrocytes, and bone marrow mesenchymal stem cells.
Sijia Liu +6 more
doaj +1 more source

